BIT:DIA - DiaSorin Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
Previous Close€73.05
Today's Range€72.15 - €73.30
52-Week Range€60.75 - €82.10
Volume56,054 shs
Average Volume113,340 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
DiaSorin S.p.A. develops, produces, and commercializes diagnostic tests in various clinical areas for hospital and private testing laboratories in the market of immunodiagnostics and molecular diagnostics. It offers immunodiagnostics products in the areas of infectious diseases; bone and mineral metabolism; endocrinology, including diabetes, thyroid function, fertility, growth, adrenal function, and gastroenterology; hypertension; oncology; stool diagnostics; autoimmunity; and cardiac and brain damages. The company's immunodiagnostics systems include LIAISON XL, an automated chemiluminescence analyzer; LIAISON analyzer; EVOlyzer 2-150/8 with disposable tips to automate microplate based assays; and ETI Max 3000, an automated microtiter plate analyzer. It also offers molecular diagnostic products LIAISON MDX a thermocycler; and LIAISON IAM, an instrument for amplification of nucleic acids, as well as kits, PCR master mixes, primer pairs, and molecular controls for monitoring oncology and infectious diseases. The company sells its products directly, as well as through an international network of independent distributors in Europe, Africa, North Americam Central America, South America, and the Asia Pacific. DiaSorin S.p.A. was founded in 1968 and is headquartered in Saluggia, Italy.

Receive DIA News and Ratings via Email

Sign-up to receive the latest news and ratings for DIA and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Laboratories & Research



Sales & Book Value

Annual SalesN/A



Next Earnings DateN/A

DiaSorin (BIT:DIA) Frequently Asked Questions

What is DiaSorin's stock symbol?

DiaSorin trades on the BIT under the ticker symbol "DIA."

Has DiaSorin been receiving favorable news coverage?

News headlines about DIA stock have trended somewhat negative this week, according to InfoTrie Sentiment. InfoTrie identifies negative and positive press coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. DiaSorin earned a news sentiment score of -1.1 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the stock's share price in the next several days.

Who are some of DiaSorin's key competitors?

What other stocks do shareholders of DiaSorin own?

Who are DiaSorin's key executives?

DiaSorin's management team includes the folowing people:
  • Mr. Carlo Rosa, CEO, GM & Exec. Director (Age 53)
  • Dr. Chen Menachem Even, Chief Commercial Officer & Exec. Director (Age 56)
  • Mr. Piergiorgio Pedron, Corp. Accounting Documents Officer, CFO & Sr. Corp. VP (Age 48)
  • Mr. Riccardo Fava, Sr. Director of Investor Relations & Corp. Communication
  • Mr. Marco Minolfo, Mang. of the Corp. Legal Affairs Department

What is DiaSorin's official website?

The official website for DiaSorin is

How can I contact DiaSorin?

DiaSorin's mailing address is via Crescentino snc, SALUGGIA, 13040, Italy. The company can be reached via phone at +39-0161-487526.

MarketBeat Community Rating for DiaSorin (BIT DIA)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  74 (Vote Outperform)
Underperform Votes:  58 (Vote Underperform)
Total Votes:  132
MarketBeat's community ratings are surveys of what our community members think about DiaSorin and other stocks. Vote "Outperform" if you believe DIA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe DIA will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/25/2019 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel